CAPR - Company ID 0001133869
The table below shows CAPRICOR THERAPEUTICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.94M | $105.42M | $19.51M | $23.24M | $28.79M | $68.38M |
| Short-term investments | - | - | $79.06M | $99.56M | $115.98M | $16.65M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $242.13M |
| $283.09M |
| $100.95M |
| $124.13M |
| $146.25M |
| $85.82M |
| Property, plant & equipment | $36.35M | $28.50M | $11.07M | $8.00M | $6.13M | $5.32M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $368.74M | $326.28M | $126.44M | $133.57M | $153.77M | $92.95M |
| Accounts payable | $3.08M | $3.93M | $2.72M | $4.81M | $5.25M | - |
| Total current liabilities | $32.96M | $33.64M | $28.15M | $28.40M | $22.34M | $20.48M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $122.52M | $47.58M | $42.57M | $28.59M | $26.12M | $24.69M |
| Retained earnings | -$379.55M | -$338.82M | -$274.71M | -$250.14M | -$224.23M | -$192.72M |
| Total equity | $246.22M | $278.70M | $83.87M | $104.98M | $127.65M | $68.26M |